Document Detail

Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver disease.
MedLine Citation:
PMID:  6521615     Owner:  NLM     Status:  MEDLINE    
Serum aminoterminal type III procollagen peptide (sPIIIP) has been proposed as an index of hepatic fibroplasia. sPIIIP was retrospectively evaluated in 34 treated and five untreated patients affected by chronic active hepatitis with or without cirrhosis by an RIA test. Serum samples taken before and after 6 months of treatment were tested in all cases. In 15 of the treated and all untreated patients, 6-20 (median 13) sera, corresponding to a median follow-up of 43 months were studied. Before treatment, the sPIIIP median value was 18.6 ng/ml; after 6 months of treatment, it decreased to 13.6 ng/ml (p less than 0.005). Follow-up sPIIIP levels were significantly lower in treated than in untreated patients (p less than 0.05), at each interval considered, except for the last control (39 months). In seven patients, treatment was discontinued: sPIIIP rose rapidly in six; four of them were retreated and this was followed by a new decrease. In four patients, sPIIIP was tested weekly from the onset of the treatment: it reverted to normal values within the first week in all cases, while GOT decreased later. sPIIIP is significantly and rapidly reduced by steroids. Steroid withdrawal is generally followed by a rebound, with a new decrease when treatment is restarted. Since sPIIIP is more rapidly lowered than GOT levels, the above data support the hypothesis that steroids can directly affect collagen metabolism.
G Ballardini; A Faccani; F B Bianchi; M Fallani; D Patrono; M Capelli; E Pisi
Related Documents :
22494585 - The impact of new technologies on radiation oncology events and trends in the past deca...
18332635 - Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperi...
23404115 - The effect of the oral pkc β inhibitor ruboxistaurin on vision loss in two phase 3 stu...
21517655 - Quality improvement program: advancement of hospital venous thromboembolism--free zones.
25336835 - Intraoperative three-dimensional fluoroscopy after transpedicular positioning of kirsch...
11898915 - Purified protein derivative reaction in systemic lupus erythematosus patients. indirect...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Liver     Volume:  4     ISSN:  0106-9543     ISO Abbreviation:  Liver     Publication Date:  1984 Dec 
Date Detail:
Created Date:  1985-03-08     Completed Date:  1985-03-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8200939     Medline TA:  Liver     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  348-52     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspartate Aminotransferases / blood
Azathioprine / therapeutic use
Drug Therapy, Combination
Hepatitis, Chronic / blood,  drug therapy*
Liver Cirrhosis / blood,  drug therapy*
Methylprednisolone / therapeutic use*
Middle Aged
Peptide Fragments / blood*
Procollagen / blood*
Retrospective Studies
Time Factors
Reg. No./Substance:
0/Peptide Fragments; 0/Procollagen; 0/procollagen Type III-N-terminal peptide; 446-86-6/Azathioprine; 83-43-2/Methylprednisolone; EC Aminotransferases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fulminant hepatic and renal failure complicating Wilson's disease.
Next Document:  Differential diagnosis of jaundice: a pocket diagnostic chart.